S9 Ep28: FDA Approval Insights: Elranatamab in Relapsed/Refractory Multiple Myeloma

OncLive® On Air - A podcast by OncLive® On Air

Podcast artwork

Dr Nooka discusses the FDA approval of elranatamab in relapsed/refractory multiple myeloma, key data from MagnetisMM-3, and the evolving role of bispecific antibodies in the multiple myeloma treatment paradigm.